Transcripts

Gilead Sciences (GILD) earnings call transcripts

Earnings call transcripts for Gilead Sciences, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as broad-based commercial and clinical execution, with HIV strength raising expectations despite temporary treatment-market disruption.

    Aug 04, 2026Confident0.86